Full-Time

Associate Director

Program Management

Posted on 5/14/2025

Deadline 7/4/25
Bristol Myers Squibb

Bristol Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

No salary listed

Senior

Company Historically Provides H1B Sponsorship

San Diego, CA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Risk Management
Requirements
  • Advanced degree (Ph.D. desirable) in Life Sciences, Chemical Sciences, Physical Sciences, or other relevant disciplines.
  • PMP certification is desirable.
  • BS/MS degrees in a scientific discipline in combination with 8+ years of drug development experience.
  • 7+ years of experience in biotech/pharmaceutical/health care industry; experience in program management or leadership of cross-functional matrix teams is a plus.
  • Experience with commonly used program management tools, including Microsoft Office Suite and Smartsheet.
Responsibilities
  • Create and drive timelines to keep program(s) on schedule. Prepare program timelines identifying all significant activities, dependencies, resources, and milestones. Conduct continual review and analysis of critical path activities and communicate any perceived risks for budget or timeline in a timely manner.
  • Challenge assumptions, timelines and expenses at the program level; pressure test plans; and create alternative scenarios, highlighting interdependencies and downstream impacts of strategic decisions.
  • Manage team meetings including developing agendas and documenting decisions and action items.
  • Proactively identify risks and ensure mitigation plans are implemented.
  • Maintain effective communication across the program team through oral and written correspondence.
  • As a program management subject matter expert, understand best practices, identify gaps and challenges, implement efficiencies and improved ways of working within the organization.
Desired Qualifications
  • PMP certification is desirable.
  • Experience in program management or leadership of cross-functional matrix teams is a plus.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet high quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, along with a strong commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing effective and affordable healthcare solutions while adhering to Environmental, Social, and Governance (ESG) principles.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's $40B US investment signals strong commitment to growth despite cost-cutting.
  • AI partnership with Optellum enhances early lung cancer diagnosis and precision care.
  • Expansion in Gulf region under new leadership boosts market presence and opportunities.

What critics are saying

  • Layoffs and facility closures may disrupt production and market demand fulfillment.
  • New leadership appointments could shift company policy, impacting ongoing projects.
  • Acquisition of 2seventy bio may pose integration challenges affecting operational efficiency.

What makes Bristol Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases, setting it apart in biopharma.
  • The company invests heavily in R&D to develop innovative and generic medicines.
  • BMS emphasizes sustainability and ESG goals, enhancing its corporate responsibility image.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Company News

BioSpace
May 6th, 2025
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans

This year alone BMS has laid off more than 800 employees, the bulk of which were just revealed this month, putting 516 jobs on the chopping block.

ROI-NJ
May 6th, 2025
Bristol Myers Squibb Names Gallman Executive Vp, General Counsel And Chief Policy Officer

Bristol Myers Squibb, the fourth-largest company in New Jersey by market cap, announced Tuesday the appointment of Cari Gallman as executive vice president, general counsel and chief policy officer, effective immediately. She succeeds Sandra (Sandy) Leung, who is retiring after a 33-year career at the company.Gallman has extensive experience in pharmaceutical law and compliance. She will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. Gallman has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as executive vice president, corporate affairs.“I am committed to continuing to build on the company’s culture of integrity and shape a dynamic policy environment that protects innovation and patients,” said Gallman in a statement.Gallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in civil, regulatory, and government enforcement matters.She earned a bachelor’s degree in political theory from Princeton University, magna cum laude, and holds a juris doctor degree from Harvard Law School

Endpoints News
May 5th, 2025
Bristol Myers to lay off over 500 workers in New Jersey

Bristol Myers to lay off over 500 workers in New Jersey.

NJBIZ
May 5th, 2025
Bristol Myers Squibb plans 500+ layoffs in NJ

BMS recently announced plans to close a manufacturing facility in Illinois that handles viral vector production.

All Blog Things
May 3rd, 2025
BMS to lay off 516 employees at its Lawrence Township facility

BMS to lay off 516 employees at its Lawrence Township facility.

INACTIVE